StonvexLoading…
StonvexStonvexStonvexCore line items from MRAM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $14.87M | $55.20M | $40.40M | $26.34M |
Operating Income | $-2.72M | $-6.51M | $-5.44M | $-3.89M |
Net Income | $-296.00K | $-586.00K | $-1.78M | $-670.00K |
EPS (Diluted) | $-0.01 | $-0.03 | $-0.08 | $-0.08 |
Total Assets | $83.19M | $84.61M | $80.27M | $78.92M |
Total Liabilities | $12.95M | $15.69M | $14.45M | $14.85M |
Cash & Equivalents | $40.49M | $44.45M | $45.26M | $44.96M |
Free Cash Flow OCF − CapEx | $-3.79M | $3.12M | $4.10M | $3.55M |
Shares Outstanding | 23.32M | 22.98M | 22.76M | 22.57M |